Somehow i missed it. Just watched it. Very interesting about the trials - there is reimbursement and we will generate revenue from each operation. I heard that they will retail for $25k and there will be 500 to 1100 people in the study...did i get that right??
if so, we are looking at $12.5m-27.5m in revenue just from the trials!
interesting about the different paths to market. Sounded like the big one is in FY26 but that we may get significant revenue from FY24 (excl. The already significant trial revenue).
please let me know if i misinterpreted anything. Glad i bought a few times recently...exciting times (at last!!)
Add to My Watchlist
What is My Watchlist?
